tofacitinib
abbvie
['u-achieve', 'upadacitinib', 'ibd']
the first oral abstract--the final results of the phase 3 u-achieve maintenance study of upadacitinib in patients with moderately to severely active #ulcerativecolitis--is presented by severine vermeire #uegweek #uegweek22 #gitwitter #ibd 
The Lancet Gastroenterology & Hepatology publishes high-quality peer-reviewed research and reviews, comment, and news #gastroenterology #hepatology. IF=45.042